Up to two years of treatment with AstraZeneca’s Fasenra (benralizumab) helped adults with eosinophilic granulomatosis with polyangiitis (EGPA)…
Articles by Marta Figueiredo, PhD
Similar to neutrophils, circulating immune macrophage cells contribute to lung bleeding and damage caused by ANCA-associated vasculitis (AAV), a study showed.
Compared with standard glucocorticoid regimen, a reduced-dose regimen may lower the risk of death and serious infections, while not increasing…
Adding plasma exchange to standard treatment reduces the risk of kidney failure after one year, but does not improve survival…
Tavneos (avacopan), in combination with rituximab, leads to high remission rates without a need for standard glucocorticoids in people…
Poor kidney function and worse overall disease severity at diagnosis can predict kidney failure in adults with ANCA-associated vasculitis…
A two-dose rituximab regimen is as safe and works as well as the standard four doses in inducing remission…
Vasculitis UK has awarded a total of £200,000 (about $283,000) in four grants to research projects mostly focused on…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…